Section 201.128 - Meaning of "intended uses"

5 Citing briefs

  1. Amarin Pharma, Inc. et al v. United States Food & Drug Administration et al

    MEMORANDUM OF LAW in Opposition re: 5 MOTION for Preliminary Injunction . . Document

    Filed June 23, 2015

    Rather, FDA’s regulations provide that intended use “refer[s] to the objective intent of the persons legally responsible for the labeling of drugs.” 21 C.F.R. § 201.128; see also Nat’l Nutritional Foods Ass’n v. Mathews, 557 F.2d 325, 334 (2d Cir. 1977). Case 1:15-cv-03588-PAE Document 51 Filed 06/23/15 Page 26 of 63 15   misleading or evidence of intended use.

  2. Peviani v. Natural Balance Inc.

    Reply to Response to 13 MOTION to Certify Class

    Filed April 25, 2011

    The intended use of a product may be determined by, among other things, its labeling, advertising, and the circumstances surrounding its distribution. 21 C.F.R. § 201.128. Such intent may even be shown where the article is, with the knowledge of its producer, being offered and used for a purpose for which it is neither labeled nor advertised.

  3. Shonkwiler v. GlaxoSmithKline, LLC

    MOTION to Dismiss Plaintiff's Complaint for Failure to State a Claim and Memorandum in Support

    Filed May 18, 2015

    (Compl. ¶ 232) (citing 21 U.S.C. §§ 331, 352; 21 C.F.R. §§ 201.57, 201.128; and 42 U.S.C. § 1320a-7b).

  4. Phelps et al v. Wyeth, Inc. et al

    Response in Opposition to Motion for Summary Judgment 301 Oral Argument requested.

    Filed August 3, 2012

    28). In fact, Dr. Phuntshog did not state that he understood 4 In addition, the FDA defines “intended use” as any use that its manufacturer “knows, or has knowledge of facts that would give him notice” is occurring 21 C.F.R 201.128. Case 6:09-cv-06168-TC Document 309 Filed 08/03/12 Page 13 of 18 PLAINTIFFS’ RESPONSE IN OPPOSITION TO DEFENDANT Page 14 PLIVA, INC.’S MOTION FOR SUMMARY JUDGMENT his long-term prescription was off-label when he wrote the prescription.

  5. Association of American Physicians and Surgeons, Inc. et al v. Food and Drug Administration et al

    MOTION to Alter Judgment, MOTION for Judgment on Partial Findings, MOTION for Leave to File Second Amended Complaint, MOTION for Reconsideration re Order on Motion to Dismiss, 42 Memorandum & Opinion

    Filed March 18, 2008

    Promotion of OTC Plan B to women under the age of 16 would create an unapproved new drug, as would sale of the product "for a purpose for which it is neither labeled nor advertised" by persons legally responsible for its labeling. 21 CFR 201.128. 2. FDA Can Enforce An Age Limit As a Practical Matter Case 1:07-cv-00668-JDB Document 45-4 Filed 03/18/2008 Page 19 of 415 Final Bracketed Comment Letter Report on Simultaneous Marketing ANPRM – Page 11 Moreover, FDA can enforce an age limitation through a variety of measures. FDA routinely requests from drug applicants commitments to implement post-market surveillance and marketing plans.